Analytical Framework for Examining the Value of Antibacterial Products. 3.2.9 Average Time to Generic Entry upon FDA Approval

04/15/2014

We estimate the average time to generic entry upon obtaining FDA approval for the drug at 12 years based on a recent study by Grabowski et al. (2011).  For sensitivity analysis, we employ a triangular distribution with endpoints of 10 and 14 years, respectively.

View full report

Preview
Download

"rpt_antibacterials.pdf" (pdf, 1.43Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®